ALCAM (CD166): its role in hematopoietic and endothelial development
Osamu Ohneda(University of Tsukuba), Toshio Suda(Chinese Academy of Sciences), Kinuko Ohneda(Tohoku University), Donald Dowbenko(University of Tsukuba), Fumio Arai(Kyushu University), James Lee(Royal Free London NHS Foundation Trust), Takeshi Miyamoto(Kumamoto Health Science University), Yoshimi Fukushima(University of Tsukuba), Laurence A. Lasky(Molecular Oncology (United States))
Cited by 161
Related Papers
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
|Proceedings of the National Academy of Sciences|1998|4.3k
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.8k
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
|Nature Genetics|2010|2.6k